Skip to main content
Clinical Trials/NCT05363566
NCT05363566
Unknown
Not Applicable

Clinical Performance of the Baska MaskⓇ, the I-GelⓇ and the Self-Pressurized Air-QⓇ i

Cairo University1 site in 1 country78 target enrollmentJune 30, 2021
ConditionsThe Baska Mask

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
The Baska Mask
Sponsor
Cairo University
Enrollment
78
Locations
1
Primary Endpoint
insertion time
Last Updated
3 years ago

Overview

Brief Summary

The Baska mask (proact Medical Ltd, Northants, UK) is the latest addition to an era of supraglottic airway devices in clinical use. It is made of medical grade silicone; it has many advantages in its constructions over other LMA, a cuff less membranous bowl in which the saliva secretion collected. An inbuilt "tab" that allows to extend its angulation for straightforward negotiation of the oropharyngeal curve during placement

Registry
clinicaltrials.gov
Start Date
June 30, 2021
End Date
November 30, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amr Samir Wahdan

Principal Investigator

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

insertion time

Time Frame: 1 hour

To determine the time taken for insertion of the device. (It will be calculated from the time of the mask will be taken away from the patient's face till the moment of the appearance of square wave capnography upstroke with the presence of sufficient ventilation) (second )

Secondary Outcomes

  • Oropharyngeal leak pressures(1 hours)
  • Ease of device insertion(1 hours)

Study Sites (1)

Loading locations...

Similar Trials